Cargando…

EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China

INTRODUCTION: Patients with type 2 diabetes have lower quality of life, which is further impaired by diabetes complications and comorbidities. This study aims to evaluate the impact of diabetes complications and comorbidities on EuroQol Five-Dimension Three-Level (EQ-5D-3L) scores among patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yichen, Wu, Jing, Chen, Yingyao, Shi, Lizheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136375/
https://www.ncbi.nlm.nih.gov/pubmed/32152932
http://dx.doi.org/10.1007/s13300-020-00788-z
_version_ 1783518234506428416
author Zhang, Yichen
Wu, Jing
Chen, Yingyao
Shi, Lizheng
author_facet Zhang, Yichen
Wu, Jing
Chen, Yingyao
Shi, Lizheng
author_sort Zhang, Yichen
collection PubMed
description INTRODUCTION: Patients with type 2 diabetes have lower quality of life, which is further impaired by diabetes complications and comorbidities. This study aims to evaluate the impact of diabetes complications and comorbidities on EuroQol Five-Dimension Three-Level (EQ-5D-3L) scores among patients with type 2 diabetes with ongoing oral drug treatments in China. METHODS: This retrospective cross-sectional analysis included 9570 patients with type 2 diabetes on oral drug treatments, who were enrolled from 75 hospitals in nine cities in China. Patient characteristics, including demographic data, health conditions, oral treatment history, and health insurance coverage, were collected through self-reported questionnaires. Health utility was measured by the EQ-5D-3L scale in the questionnaire and a Chinese version of the EQ-5D-3L scoring weights was applied in the analysis. The associations between complications and health utility were assessed using linear regression. RESULTS: A total of 7081 patients with complete survey data were included in the analytic sample; 3479 (49.13%) patients were female. The mean age was 59.6 years old, with a standard deviation (SD) of 12.64. The average duration with type 2 diabetes was 7.91 (SD = 6.22) years. A total of 5189 (73.28%) patients reported complications. Hypertension (51.25%) and hyperlipidemia (28.90%) were the most common complications. Other complications reported by patients included cardiovascular disease, stroke, retinopathy, nephropathy, diabetic foot, and hypoglycemia. On average, each patient had 1.54 complications. All complications and comorbidities decreased the EQ-5D-3L score. Among patients with complications, the worst effect on EQ-5D-3L score was caused by diabetic foot, decreasing by 0.118 (p < 0.001), followed by stroke (decreasing by 0.101, p < 0.001) and nephropathy (decreasing by 0.058, p < 0.001). CONCLUSION: The diabetes complications and comorbidities among patients with type 2 diabetes were associated with poor health utility scores, especially for those with diabetic foot, stroke, and nephropathy.
format Online
Article
Text
id pubmed-7136375
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-71363752020-04-09 EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China Zhang, Yichen Wu, Jing Chen, Yingyao Shi, Lizheng Diabetes Ther Original Research INTRODUCTION: Patients with type 2 diabetes have lower quality of life, which is further impaired by diabetes complications and comorbidities. This study aims to evaluate the impact of diabetes complications and comorbidities on EuroQol Five-Dimension Three-Level (EQ-5D-3L) scores among patients with type 2 diabetes with ongoing oral drug treatments in China. METHODS: This retrospective cross-sectional analysis included 9570 patients with type 2 diabetes on oral drug treatments, who were enrolled from 75 hospitals in nine cities in China. Patient characteristics, including demographic data, health conditions, oral treatment history, and health insurance coverage, were collected through self-reported questionnaires. Health utility was measured by the EQ-5D-3L scale in the questionnaire and a Chinese version of the EQ-5D-3L scoring weights was applied in the analysis. The associations between complications and health utility were assessed using linear regression. RESULTS: A total of 7081 patients with complete survey data were included in the analytic sample; 3479 (49.13%) patients were female. The mean age was 59.6 years old, with a standard deviation (SD) of 12.64. The average duration with type 2 diabetes was 7.91 (SD = 6.22) years. A total of 5189 (73.28%) patients reported complications. Hypertension (51.25%) and hyperlipidemia (28.90%) were the most common complications. Other complications reported by patients included cardiovascular disease, stroke, retinopathy, nephropathy, diabetic foot, and hypoglycemia. On average, each patient had 1.54 complications. All complications and comorbidities decreased the EQ-5D-3L score. Among patients with complications, the worst effect on EQ-5D-3L score was caused by diabetic foot, decreasing by 0.118 (p < 0.001), followed by stroke (decreasing by 0.101, p < 0.001) and nephropathy (decreasing by 0.058, p < 0.001). CONCLUSION: The diabetes complications and comorbidities among patients with type 2 diabetes were associated with poor health utility scores, especially for those with diabetic foot, stroke, and nephropathy. Springer Healthcare 2020-03-09 2020-04 /pmc/articles/PMC7136375/ /pubmed/32152932 http://dx.doi.org/10.1007/s13300-020-00788-z Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Zhang, Yichen
Wu, Jing
Chen, Yingyao
Shi, Lizheng
EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China
title EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China
title_full EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China
title_fullStr EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China
title_full_unstemmed EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China
title_short EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China
title_sort eq-5d-3l decrements by diabetes complications and comorbidities in china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136375/
https://www.ncbi.nlm.nih.gov/pubmed/32152932
http://dx.doi.org/10.1007/s13300-020-00788-z
work_keys_str_mv AT zhangyichen eq5d3ldecrementsbydiabetescomplicationsandcomorbiditiesinchina
AT wujing eq5d3ldecrementsbydiabetescomplicationsandcomorbiditiesinchina
AT chenyingyao eq5d3ldecrementsbydiabetescomplicationsandcomorbiditiesinchina
AT shilizheng eq5d3ldecrementsbydiabetescomplicationsandcomorbiditiesinchina